Colorectal Surgery Malpractice Is More Common Than You Think

Colon and rectal surgeries, collectively referred to as colorectal surgeries, account for about 24% of all general surgery cases and about 15% of the physicians in this field face medical malpractice lawsuits each year. A study published in the Journal of Surgical Research analyzed 122 medical malpractice lawsuits and found that the most common cause…

Read More

Women Are Being Over-Prescribed with Opioids After C-Sections

According to a recent study conducted at Vanderbilt University Medical Center and published in the journal Obstetrics and Gynecology, women who undergo Cesarean sections have been routinely overprescribed opioid (narcotic) pain medications. The study looked at 179 patients who had undergone cesareans at VUMC over an eight-week period to examine opioid prescribing practices and consumption…

Read More

The Difference Between a Birth Defect and Birth Injury

Parents and other family members of children who are the victims of preventable injuries at birth due to substandard care provided by medical personnel during pregnancy, labor, or delivery have the option to pursue legal action. Cases that involve birth injury often involve an allegation that medical staff fell short in their obligation to deliver…

Read More

Surgical Malpractice – “Never Events” That Occur Too Often

Even the most simple of surgeries can elicit concern for patients. While surgeons and other medical professionals are highly trained in their craft, human error is always a possibility. Beyond simple errors, there is also the potential for acute carelessness and negligence that can result in serious complications or injury. Surgical malpractice can produce long-term…

Read More

Limbrel Capsules Deemed by the FDA as an Unapproved Drug

The Food and Drug Administration (FDA) has suggested that use of the product known as Limbrel may inflict a life-threatening injury to the liver in addition to promoting the development of pancreatitis and hypersensitivity pneumonitis. In November 2017, the FDA issued a warning concerning Limbrel, which Primus Pharmaceuticals, the company that markets the product, designates…

Read More